Roche offers to buy Illumina for about $5.7 billion
by admin on Wednesday, January 25th, 2012 | No Comments
(Reuters) – Swiss drugmaker Roche Holding AG existing about $5.7 billion in cash to buy U.S. gene sequencing device maker Illumina Inc , in a potentially hostile takeover bid to boost its spot in life sciences and diagnostics.
View full post on Reuters: Business News
